Granules India Limited has announced that its board of directors will convene on April 29, 2026, to consider and approve the company's audited financial results for the fourth quarter and full financial year ended March 31, 2026. Additionally, the company has scheduled an earnings conference call on the same day to discuss financial performance and business updates.

Board Meeting and Results Announcement

The pharmaceutical company issued a formal notice on April 16, 2026, to the National Stock Exchange of India Limited and BSE Limited under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting will also consider the recommendation of final dividend for FY 2025-26, if any.

Earnings Conference Call Details

Granules India has scheduled an analyst and investor earnings conference call for Q4 and the financial year ended March 31, 2026, at 5:00 PM IST on April 29, 2026. The call will feature senior management discussing the company's financial performance and providing business updates.

Trading Window Restrictions

In connection with the board meeting, Granules India Limited has announced that the insider trading window will remain closed until Friday, May 1, 2026. This temporary restriction is implemented as a standard compliance measure during the period of financial result considerations.

Corporate Compliance

Both announcements were signed by Chaitanya Tummala, Company Secretary & Compliance Officer, and communicated to major stock exchanges where the company is listed. The earnings call notification was issued under Regulation 30 of the SEBI regulations, while the board meeting notice follows Regulation 29 requirements. The company's registered office is located at the 15th Floor, Granules Tower, Botanical Garden Road, Kondapur, Hyderabad, Telangana.

Granules India Limited has formally communicated to the National Stock Exchange of India regarding its classification status under SEBI regulations. The pharmaceutical company has confirmed that it does not meet the criteria for Large Corporate classification as outlined in the regulatory framework.

Regulatory Classification Status

The company has officially stated that it does not fall under the Large Corporate category as per the criteria specified in SEBI circular no. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. This notification serves as a formal compliance measure to keep the exchange informed about the company's current regulatory status.

Compliance Commitment

Granules India Limited has provided a formal undertaking to the National Stock Exchange, committing to inform the exchange as and when the company becomes a Large Corporate as per the aforementioned SEBI circular. This proactive approach ensures ongoing regulatory compliance and transparency with market regulators.

The undertaking was digitally signed by Chaitanya Tummala, who serves as the Company Secretary and Compliance Officer for Granules India Limited. The digital signature was executed on April 8, 2026, at 15:07:49 +05'30', providing a timestamped record of the formal communication.

Company Information

Granules India Limited operates from its registered office located at the 15th Floor, Granules Tower, Botanical Garden Road, Kondapur, Hyderabad – 500084, Telangana, India. The company holds CIN: L24110TG1991PLC012471 and maintains its corporate communications through established channels including telephone, fax, and email services.